Sign in

Sionna Therapeutics, Inc.

Dec-25 Dec-24 Dec-23 Dec-22
Total revenue 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00
Gross profit 0.00 0.00
Total operating expenses + 0.09 0.07 0.05 0.04
Operating income -0.09 -0.07 -0.05 -0.04
Non-operating income (net) 0.01 0.01 0.00 0.00
Income before tax -0.08 -0.06 -0.05 -0.04
Net income -0.08 -0.06 -0.05 -0.04
Show Quarterly Income Statement
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23
Total revenue 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Cost of revenue 0.00 0.00 0.00 0.00 0.00
Gross profit 0.00 0.00 0.00 0.00 0.00
Total operating expenses + 0.03 0.02 0.02 0.02 0.02 0.02 0.03 0.01 0.01 0.01
Operating income -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.01 -0.01 -0.01
Non-operating income (net) 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00 0.00
Income before tax -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.01 -0.01 -0.01
Net income -0.03 -0.02 -0.02 -0.02 -0.02 -0.02 -0.03 -0.01 -0.01 -0.01
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Total cash and short-term investments + 0.24 0.15 0.04 0.08
Other current assets 0.01 0.00 0.00 0.00
Total current assets 0.24 0.15 0.04 0.08
Total non-current assets + 0.08 0.03 0.01 0.00
Total assets 0.33 0.19 0.05 0.09
Total current liabilities + 0.01 0.01 0.01 0.01
Total non-current liabilities + 0.01 0.34 0.16 0.15
Total liabilities 0.02 0.35 0.17 0.16
Total stockholders' equity + 0.31 -0.16 -0.11 -0.07
Common shares outstanding 40 44 44 44
Show Quarterly Balance Sheet
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23
Total cash and short-term investments + 0.22 0.24 0.25 0.26 0.27 0.15 0.14 0.00 0.00 0.04
Other current assets 0.00 0.01 0.00 0.00 0.00 0.00 0.00 0.00
Total current assets 0.22 0.24 0.25 0.27 0.27 0.15 0.14 0.04
Total non-current assets + 0.08 0.08 0.09 0.09 0.10 0.03 0.06 0.01
Total assets 0.31 0.33 0.34 0.35 0.37 0.19 0.20 0.05
Total current liabilities + 0.01 0.01 0.01 0.01 0.01 0.01 0.01 0.01
Total non-current liabilities + 0.01 0.01 0.01 0.01 0.01 0.34 0.34 0.16
Total liabilities 0.02 0.02 0.02 0.02 0.02 0.35 0.35 0.17
Total stockholders' equity + 0.29 0.31 0.32 0.34 0.35 -0.16 -0.15 -0.11
Common shares outstanding 45 40 44 44 44 44 44 44 44 44
4 days ago
Dec-25 Dec-24 Dec-23 Dec-22
Operating cash flow + -0.07 -0.05 -0.04 -0.04
Cash flow from investing + -0.12 -0.13 0.03 -0.03
Cash flow from financing + 0.21 0.18 0.00 0.11
Change in cash 0.02 0.00 -0.02 0.05
Show Quarterly Cash Flow
Mar-26 Dec-25 Sep-25 Jun-25 Mar-25 Dec-24 Sep-24 Jun-24 Mar-24 Dec-23
Operating cash flow + -0.02 -0.02 -0.02 -0.02 -0.02 -0.01 -0.02 -0.01 -0.01 -0.01
Cash flow from investing + 0.02 0.02 0.02 -0.02 -0.14 0.02 0.01 -0.03 -0.12 0.01
Cash flow from financing + 0.00 0.00 0.00 0.00 0.20 0.00 0.00 0.00 0.18 0.00
Change in cash 0.00 0.01 0.01 -0.04 0.04 0.00 -0.01 -0.04 0.04 0.00
4 days ago

Sionna Therapeutics, Inc. (SION) - Cashflow From Financing

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Cashflow From Investment

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Capital Expenditures

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Depreciation Depletion And Amortization

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Operating Cashflow

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Net Income

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Ebitda

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Ebit

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Net Income From Continuing Operations

1Y 2Y 5Y Max
8 days ago

Sionna Therapeutics, Inc. (SION) - Income Before Tax

1Y 2Y 5Y Max
8 days ago